baber/WOPTO huggingface dataset:
Patent NZ-217390-A (NZ)
Title: Process and apparatus for producing synthesis gas
Inventor: SIE S T
IPC: C01B3/02
Filed: 1986-08-28
Abstract: A process for producing synthesis gas by catalytic reforming of hydrocarbons with steam in a reaction zone which is subjected to heat exchange with a combustion gas and recycling heat exchanged combustion gas to a combustion zone. The invention further relates to an apparatus suitable for said process.
Patent NZ-228645-A (NZ)
Title: 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
Inventor: BELLEAU BERNARD
IPC: A61K31/52
Filed: 1989-04-07
Abstract: There is provided novel 2-substituted-4-substituted-1,3-dioxolanes which are particularly useful as antiviral agents.
Patent NZ-232314-A (NZ)
Title: Semipermeable membranes comprised of a blended aromatic polyamide and polyvinylpyrrolidone
Inventor: HAUBS MICHAEL
IPC: C08L77/10
Filed: 1990-01-31
Abstract: A semipermeable membrane is described which comprises a homogeneously miscible polymer blend of an aromatic polyamide and polyvinylpyrrolidone. The aromatic polyamide is in particular formed of recurrent units of the formula I:   <IMAGE> (I)  wherein E1 and E2 are identical or different and are selected from the groupings <IMAGE>  <IMAGE>  -AR1-, and -AR1-X-AR2, where AR1 and Ar2 are the same or different 1,2-phenylene, 1,3-phenylene or 1,4-phenylene groups which may be substituted by (C1-C6)-alkyl, (C1-C6)-alkoxy, -CF3 or halogen and X denotes a) a direct bond or one of the following divalent groups: -O-, -C(CF3)2-, -SO2-, -C(R1)2-, with R1 being hydrogen, (C1-C6)-alkyl or fluoroalkyl having from 1 to 4 carbon atoms in the alkyl group or -Z-AR1-Z-, where Z is one of the groups -O- and -C(CH3)2 or -O-Ar1-Y-Ar2-O-, where Y has the meaning given under Xa) above. The membrane has pronouned hydrophilic properties and is moreover stable to hydrolyzing agents and oxidants and to the action of heat. It is also resistant to organic solvents and microorganisms and exhibits low adsorption of proteins. A process for producing the membrane and a process for modifying the retention capacity thereof are also described. The membrane is produced by spreading a solution of the homogeneously miscible polymer blend on a planar substrate and precipitating the blend. Retention capacity is modified by heat treatment.
Patent NZ-233088-A (NZ)
Title: Hydroxyalkylfuranyl derivatives and pharmaceutical compositions
Inventor: JANSSENS FRANS EDUARD
IPC: A61K31/495
Filed: 1990-03-26
Abstract: Hydroxylalkylfuranyl derivatives of formula <CHEM>  wherein -A<1>=A<2>-A<3>=A<4>- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -CH=N-CH=CH-, -CH=CH-N=CH-, -CH=CH-CH=N-, -N=CH-N=CH- or -CH=N-CH=N- ;  D is C1-4alkanediyl ;  R<1> is hydrogen, C1-6alkyl, arylC1-6alkyl or C1-6alkylcarbonyl ;  R<2> and R<3> are hydrogen or C1-6alkyl ;  n is 0, 1 or 2 ;  B is NR<4>, O, S, SO2 or CH2;  R<4> is hydrogen, C1-6alkyl, C3-6cycloalkyl or arylC1-6alkyl ; L is hydrogen, C1-12alkyl, C3-6cycloalkyl, C3-6alkenyl optionally substituted with aryl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, arylcarbonyl, arylC1-6alkyloxycarbonyl, C1-6alkylsulfonyl, arylsulfonyl, or a radical of formula -Alk-R<5>, -Alk-Y-R<6>, -Alk-Z<1>-C(=X)-Z<2>-R<7>, or -CH2-CHOH-CH2-O-R<8>, the acid addition salts and stereochemically isomeric forms thereof, said compounds having antiallergic activity. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
Patent NZ-240655-A (NZ)
Title: Processed cheese containing a modified starch or an esterified pectin
Inventor: MERENICH KARL
IPC: A23C19/082
Filed: 1991-11-19
Abstract: A novel type of processed cheese preparation is described, composed of cheese, fat, emulsifying salts, water and conventional additives such as emulsifiers, binders, thickeners, curd cheese, milk protein and flavourings in the conventional amounts, trisodium citrate and/or sodium phosphate being used as the emulsifying salts in a quantity of 1.5 - 3% and the mixture containing a modified starch having high amylopectin and low amylose content and/or highly esterified pectin in an amount of 0.25 - 2%.
Patent NZ-253999-A (NZ)
Title: Pelletised substained release medicament
Inventor: MORELLA ANGELO MARIO
IPC: A61K9/22
Filed: 1993-07-23
Abstract: A pelletized sustained release pharmaceutical composition including a core element including approximately 0.1 to 95% by weight, based on the total weight of the core element, of an active ingredient of low aqueous solubility; approximately 0.1 to 55% by weight of a core seed; and a core coating for the core element, including approximately 30 to 97% by weight, based on the total weight of the core coating, excluding filler, of an enteric polymer; approximately 3 to 50% by weight of an insoluble polymer; and 0 to approximately 50% by weight of plasticizer, the enteric polymer comprising at least approximately 70% by weight of the total weight of the enteric polymer and insoluble polymer; the core coating being such that the active ingredient is released in a controlled fashion over an extended period in the intestine but substantially no release occurs in the acid environment of the stomach and blood levels of active ingredient are maintained within the therapeutic range over an extended period of time.
Patent NZ-296121-A (NZ)
Title: Bitumen compositions contain succinic anhydride derivative
Inventor: DESAIX JEAN-CLAUDE
IPC: C08K5/04
Filed: 1995-11-20
Abstract: Bitumen compositions comprising bitumen and at least one succinic anhydride derivative contained in the bitumen, processes for their preparation and their use in bitumen emulsions for road applications, e.g. surface dressings.
Patent NZ-296267-A (NZ)
Title: Mattress innerspring construction, springs have independent terminal convolutions
Inventor: WAGNER ROBERT F
IPC: A47C27/04
Filed: 1995-10-20
Abstract: An innerspring assembly, such as for use in a mattress, comprises a plurality of coil springs defining upper and lower terminal convolutions and body portions therebetween. Adjacent coil springs are attached together at the body portions thereof with the terminal convolutions being unattached to one another, so that the terminal convolution can move independently of one another.
Patent NZ-329326-A (NZ)
Title: Paint stripper containing n-methylpyrrolidone or dimethyl sulphoxide and benzyl alcohol
Inventor: LALLIER JEAN-PIERRE
IPC: C09D9/00
Filed: 1997-12-04
Abstract: Composition for stripping paints, lacquers, or primers consists of 5-90 pts.wt. water; 2-47.5 pts.wt. benzylic acid; and 2-47.5 pts.wt. dimethylsulphoxide or N-methylpyrrolidone. Also claimed is the method for stripping paint, varnish or lacquer by applying the composition to substrate in heated bath for sufficient time to remove the paint.
Patent NZ-332217-A (NZ)
Title: Method of stabilizing the viscosity of a thickened composition
Inventor: SVOBODA GEORGE J
IPC: C11D3/37
Filed: 1997-03-31
Abstract: method is disclosed for stabilizing a composition containing a thickening agent which is adversely affected by the increasing ionic strength of the composition, by blanketing the solution in a vessel with a sufficient amount of gas capable of diluting or displacing the atmospheric air in the headspace of the vessel.
Patent NZ-335999-A (NZ)
Title: Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells
Inventor: REINHARD MARK S
IPC: A01N63/00
Filed: 1996-11-06
Abstract: A composition for the treatment of vaginal yeast which promotes normal vaginal bacterial growth during treatment, comprising a yeast-inhibitory agent selected from one or more of the group consisting of ethylene glycol, propylene glycol, and glycerol, an effectively buffered aqueous acetate solution and cells of a Lactobacillus species. In the composition the concentration of acetate is effective to establish a pH of the composition in the range of from about 5 to about 7, the presence of unionized acetate inhibits yeast selectively compared to the bacteria, and the proportions of the yeast inhibitory agent and the buffering solution are effective to allow the active yeast-inhibitory agent to inhibit the vaginal yeast Candida.
Patent NZ-500850-A (NZ)
Title: Method of coating cellulosic and lignocellulosic webs
Inventor: DETTLING BERNHARD
IPC: D21H23/30
Filed: 1998-04-16
Abstract: A method for coating paper, wherein a coating composition containing coating particles is applied to the surface of a paper web containing lignocellulosic fibres to produce a coated paper web having coating particles bound to the paper web, and the coated web is dried. According to the method the surface area of the interface between the paper web and the coating particles is increased in order to enhance hydrogen bonding between the coating particles and the fibres of the web.  The surface area can be increased by using a coating composition comprising fine fibrous material or by abrading the surface of the paper or paperboard web or both.  The method will improve the smoothness of the surface without addition of foreign polymer binding agents to the web.
Patent NZ-501366-A (NZ)
Title: Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas
Inventor: MARY VERONIQUE
IPC: A61K31/727
Filed: 1998-05-25
Abstract: The specification describes the use of a low-molecular-weight heparin with an average MW of 1,000 to 10,000 in the preparation of a medicament for the prevention or treatment of cerebral oedemas.
Patent NZ-513349-A (NZ)
Title: Polypeptides involved in immune response
Inventor: YOSHINAGA STEVEN KIYOSHI
IPC: A61P1/04
Filed: 2000-01-27
Abstract: Disclosed are polypeptides that comprise a receptor- ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding said polypeptides, and vectors and host cells for expressing same are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders, regulate T-cell activation or proliferation or to suppress an immune response in an animal.
Patent NZ-514741-A (NZ)
Title: Transmission device for ultrasonic imaging system
Inventor: NIERICH ARNO
IPC: A61B8/00
Filed: 2000-03-10
Abstract: An ultrasonic imaging system (6) comprising an ultrasound endoscope device (7) for scanning a patient's organs (9), in particular for use in transesophageal echocardiography, associated with a separate transmission device (8) defining a transmission path for sound waves originating from the endoscope device. Also disclosed is a transmission device (8) specially adapted for use in association with an endoscope device (7) in an ultrasonic imaging system (6) comprising a flexible balloon member (13) connected to a supply line (10) for a sound wave transmission fluid medium. Also disclosed is the use of an ultrasonic imaging system (6) and a method for ultrasonic scanning a patient's organs (9) in particular in transesophageal echocardiography.
Patent NZ-514861-A (NZ)
Title: Tethering apparatus and inertia locking reel
Inventor: BAKER CAMERON MACMILLAN
IPC: A01K97/22
Filed: 2000-03-16
Abstract: A tethering apparatus (14) including a harness (15), an anchor (16) and a line member (17) wherein said line member (17) connects said harness (15) to said anchor (16), further including a spool (19) about which the line member (17) is wound, said spool (19) having an inertia lock (18) for arresting the spool (19) when the line member (17) is unwound from the spool (19) at a rate above a predetermined value. The inertia lock (18) preferably includes a housing having an inner surface in the form of a ratchet (32), and a pawl (37) mounted for rotation about an axis substantially parallel to and offset from the axis about which the spool (19) rotates and wherein said pawl (37) is biased to a disengaged condition where the pawl (37) is disengaged from the ratchet (32) and wherein said pawl (37) engages the ratchet (32) and arrests the spool (19) when the line member (17) is unwound from the spool (19) at a rate above a predetermined value.
Patent NZ-516474-A (NZ)
Title: Container handling apparatus
Inventor: SCHMIDT HANS HEINRICH
IPC: B65D90/18
Filed: 2000-07-06
Abstract: A container handling apparatus utilising a cradle  (1) having a chassis (2) adapted specifically for attachment  to the  top  of  the shipping container (C) and having  lifting legs  (3)  attached  to  each  corner  of  the  chassis  and incorporating lifting rams. The legs are pivotably  attached at  pivot  points to the respective corners  whereby  to  be swung  between positions extending alongside the chassis  in a  stored  orientation  and positions  extending  downwardly from  the  chassis  in  a ground engaging  orientation.  The pivotable  attachments for said lifting legs are  such  that the  positions  of  the legs can be extended  and  retracted laterally of the chassis, whilst in the lower ends  of  said legs  carry wheels (8) for mobility whereby the cradle  with the  legs extending downwardly from the chassis in a  ground engaging   orientation   with,  or  without,   a   container suspended  beneath  said chassis,  can  be  moved  from  one position  to  another.  The  pivotable  attachments  of  the lifting  legs  to  said chassis are such  that  the  lateral movement   of  said  legs,  and  their  pivotable  movement, relative to said chassis is accomplished simultaneously,  or independently.  The corners of the chassis have  means  (16) for  attachment thereof to the top corners of said container and  the  chassis has recesses (32) extending longitudinally thereof between the means for attaching the chassis, and  on each  side thereof, for accommodating the legs when  in  the stored orientation.
Patent NZ-517351-A (NZ)
Title: Light chamber for belly door for gaming machine
Inventor: SOKOLOV RICHARD
IPC: A63F13/08
Filed: 2000-11-08
Abstract: A belly door for a gaming machine includes a frame for receiving a sheet of artwork and a light reflective chamber having an open face which is located behind the frame when in a closed position. Clamping means are provided for clamping the artwork between the frame and the chamber. A recess extends along one edge of the chamber including sockets for receiving a fluorescent light tube when the chamber is in the closed position. A diffuser panel is disposed in the chamber behind the artwork located so as to be edge lit by the fluorescent light tube. The reverse face of the panel, which in use, faces the rear wall of the chamber defines a series of white opaque dots which in use, diffuse and direct the light in a forward direction perpendicular to the plane of the panel. The size of the dots in the panel increases with the distance of the dots from the fluorescent light tube. This arrangement ensures that the light panel produces a very evenly balanced lighting of the artwork.
Patent NZ-521686-A (NZ)
Title: A member of the selectin ligand interactor cytoplasmic (SLIC-1) protein familys
Inventor: LORENZ MEIKE
IPC: C12Q1/6883
Filed: 2001-03-23
Abstract: An isolated nucleic acid molecule comprises the nucleotide set forth in SEQ ID NO:1 encodes SLIC-1 and the corresponding polypeptide comprises the amino acid sequence set forth in SEQ ID NO:2 . Vectors, host cells, antibodies, methods of producing the polypeptide and methods of detecting the polypeptide or nucleic acid molecule in sample are described. Antibodies that bind the polypeptide or polypeptides comprising the cytoplasmic domain of PSGL- I can be used in pharmaceutical compositions for treating SLIC-1 associated disorders.
Patent NZ-524963-A (NZ)
Title: Occupant restraint: safety belt for operators of construction or road working equipment
Inventor: WILKINSON DONALD RAYMOND
IPC: B60R22/00
Filed: 2001-09-19
Abstract: A restraint (1) for a vehicle which includes an extension (4) adapted in use to be positioned over the body of a vehicle occupant, a connector (5) which when engaged is adapted to secure the extension (4) over the body of a vehicle occupant, and a biasing means associated with the extension (4) adapted to locate at least a portion of the extension (4) in a position where it will at least attract the attention of the vehicle occupant when the connector (5) is not engaged
Patent NZ-526542-A (NZ)
Title: Pyrimidineamines as angiogenesis modulators
Inventor: BOLOOR AMOGH
IPC: A61K31/506
Filed: 2001-12-19
Abstract: Pyrimidine derivatives of formula (I), which are useful as VEGFR2 inhibitors are described. Also described are methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Patent NZ-530524-A (NZ)
Title: Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
Inventor: PEVARELLO PAOLO
IPC: A61K31/426
Filed: 2002-07-02
Abstract: Disclosed is a phenylacetamido-thiazole derivative represented by formula (I) wherein: R is H or alkyl; R1 is as defined; R2 is H or alkyl; R3 is selected from amino, aminomethyl, hydroxymethyl, alkyl or a 5-6 membered heterocycle with 1 or 2 heteroatoms selected from N, O or S. Provided that when R is H, R3 is other than methyl, or pyridyl-3-yl. Also disclosed is the use compounds of formula (I) in the manufacture of a medicament for treating a cell proliferative disorder associated with an altered cell cycle dependent kinase activity. In particular disorders such as cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders are disclosed.
Patent NZ-531877-A (NZ)
Title: Apparatus and method for bioelectric stimulation, healing acceleration and pain relief
Inventor: KRONBERG JAMES W
IPC: A61N1/32
Filed: 2002-08-21
Abstract: A signal generator suitable for generating waveforms for a variety of diverse biomedical electrotherapy applications includes a timing circuit 92 for generating intervals T1 and T2 and also T5 and T6, a second timing circuit 94 which generates intervals T3 and T4 and T7, an interconnection circuit 96 which combines the signals from the circuits 92 and 94 so that a succession of intervals T1 and T2 appear only during the intervals T3, a voltage and current switch 98 which generates an output signal at a usable amplitude, and a filter 102 which removes unwanted signal components and sets transition and decay time constants. A connection circuit 104 passes the signal out to a load such as a cell, tissue, organ, or organism. Energy for the generator is supplied by a power supply 108 including a battery. The intervals T1 and T2 are intervals in which opposite phases of a rectangular wave of frequency between 200Hz and 20 KHz are generated to the output of the generator. The respective intervals comply with the constraints that: The period T1 is at least twice that of T2 and no greater than twenty times T2. The sum of T1 and T2 is at least 50 microseconds and no greater than 5 milliseconds. T3 is at least 10 times T1. Both T4 and T7 are no greater than 500 milliseconds. Both T5 and T6 are no greater than T1. The sum of T3, T4, and T7 is at least 5 milliseconds and no greater than 500 milliseconds.
Patent NZ-534417-A (NZ)
Title: A communication device for joining a user to a group call in a group communication network
Inventor: CROCKETT DOUGLAS M
IPC: H04Q1/00
Filed: 2003-02-12
Abstract: A method and apparatus for joining a user to a call in a group communication network provides for receiving an indication from a user who wishes to initiate a group call and sending a request to a server to add the user to the group call if the group call is in progress. The method and apparatus also provides for receiving a response from the server indicating that the group call is in progress, alerting the user of being added to the group call, and receiving media from the server after a traffic channel is re-established. The method and apparatus also provides for a significant reduction in the actual total dormancy wakeup time and latency by exchanging group call signalling even when mobiles are dormant and no traffic channel is active.
Patent NZ-534613-A (NZ)
Title: Methods of simultaneously treating ocular rosacea and acne rosacea with a tetracycline compound
Inventor: ASHLEY ROBERT A
IPC: A61K31/65
Filed: 2003-04-16
Abstract: Use of a tetracycline compound in the manufacture of a medicament for the simultaneous treatment of ocular rosacea and acne rosacea is disclosed, wherein the medicament is formulated for systemic administration and the tetracycline compound has substantially no antibiotic activity.
Patent NZ-535008-A (NZ)
Title: Polymer-based compositions for sustained release
Inventor: TRACY MARK A
IPC: A61K9/22
Filed: 2003-02-07
Abstract: Sustained release compositions, and methods of forming and using said compositions, in particular for the sustained release of Follicle Stimulating Hormone (FSH), are disclosed. The sustained release compositions comprise a polymeric matrix of a biodegradable biocompatible polymer, such as a poly(lactide-co-glycolide) copolymer, and stabilized FSH. The disclosed method for forming a sustained release composition includes, dissolving a biodegradable biocompatible polymer in a polymer solvent to form a polymer solution; adding biologically active stabilized FSH; removing the solvent; and solidifying the polymer to form a polymer matrix containing stabilized FSH dispersed therein. Also described is a method for providing a therapeutically effective amount of stabilized FSH in a patient in need of for a sustained period comprising administering to the patient a dose of the sustained release compositions of the invention. The sustained release composition of FSH can be used to promote maturation of follicles, promote spermatogenesis and to treat fertility disorders.
Patent NZ-537244-A (NZ)
Title: Improvements in or relating to vibration analysis
Inventor: LEIGH NIGEL
Filed: 2004-12-16
Abstract: Method of deriving multiple types of vibration signals from one vibration signal for vibration analysis comprising the steps of: measuring the vibrations of an object using at least one vibration sensor, wherein the vibration sensor converts vibrations into an electrical vibration signal; digitising the electrical vibration signal based on a first frequency, wherein the first frequency is selected from a plurality of possible frequency values; deriving a first type of vibration signal from the digitised vibration signal; and deriving a second type of vibration signal from the digitised vibration signal based on a second frequency, wherein the second frequency is rationally determined from and lower than the value selected for the first frequency.
Patent NZ-538989-A (NZ)
Title: Magnetic conditioning apparatus for diesel engine fuel with deviating constrained path having opposed magnets along path
Inventor: TURI CARLO
IPC: F02B51/04
Filed: 2003-09-26
Abstract: Disclosed is a magnetic conditioning device for diesel engine fuel comprising a hosing element, placed along the fuel feeding line, having a fuel inlet and a fuel outlet, and providing a septum in correspondence of the inlet to deviate the inlet fuel, and a constrained path for the fuel, being provided with at least two opposed magnetic elements, so as along said constrained path, inducing a magnetic field on the flowing fuel.
Patent NZ-539778-A (NZ)
Title: Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases
Inventor: JACOBS MARTIN J
IPC: A61K9/48
Filed: 2003-10-24
Abstract: A pharmaceutical composition comprising a solid dispersion of a modafinil compound in at least one solid state carrier is disclosed, wherein the modafinil compound is present at a concentration in excess of its saturation solubility at room temperature in the solid state carrier, such that the modafinil compound is separated as a solid phase dispersed in the composition, and wherein the solid state carrier comprises polyethylene glycol having an average molecular weight of about 3,000 to about 8,000 Daltons.